Lindgren P - Search Results

1

The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov model.

Jönsson L, Lindgren P, Wimo A, Jönsson B, Winblad B. Jönsson L, et al. Among authors: lindgren p. Clin Ther. 1999 Jul;21(7):1230-40. doi: 10.1016/S0149-2918(00)80025-9. Clin Ther. 1999. PMID: 10463520

2

Costs of Mini Mental State Examination-related cognitive impairment.

Jönsson L, Lindgren P, Wimo A, Jönsson B, Winblad B. Jönsson L, et al. Among authors: lindgren p. Pharmacoeconomics. 1999 Oct;16(4):409-16. doi: 10.2165/00019053-199916040-00008. Pharmacoeconomics. 1999. PMID: 10623368

3

Cost-effectiveness analysis of exemestane compared with megestrol in advanced breast cancer: a model for Europe and Australia.

Lindgren P, Jönsson B, Redaelli A, Radice D. Lindgren P, et al. Pharmacoeconomics. 2002;20(2):101-8. doi: 10.2165/00019053-200220020-00003. Pharmacoeconomics. 2002. PMID: 11888362

4

Modeling the progression of rheumatoid arthritis: a two-country model to estimate costs and consequences of rheumatoid arthritis.

Kobelt G, Jönsson L, Lindgren P, Young A, Eberhardt K. Kobelt G, et al. Among authors: lindgren p. Arthritis Rheum. 2002 Sep;46(9):2310-9. doi: 10.1002/art.10471. Arthritis Rheum. 2002. PMID: 12355478 Free article.

5

Cost-effectiveness of primary prevention of coronary heart disease through risk factor intervention in 60-year-old men from the county of Stockholm--a stochastic model of exercise and dietary advice.

Lindgren P, Fahlstadius P, Hellenius ML, Jönsson B, de Faire U. Lindgren P, et al. Prev Med. 2003 Apr;36(4):403-9. doi: 10.1016/s0091-7435(02)00060-9. Prev Med. 2003. PMID: 12649048 Clinical Trial.

6

Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long-term model based on the CURE trial.

Lindgren P, Jönsson B, Yusuf S. Lindgren P, et al. J Intern Med. 2004 May;255(5):562-70. doi: 10.1111/j.1365-2796.2004.01324.x. J Intern Med. 2004. PMID: 15078498 Free article. Clinical Trial.

7

The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study.

Lamy A, Jönsson B, Weintraub WS, Zhao F, Chrolavicius S, Bakhai A, Culler S, Gafni A, Lindgren P, Mahoney E, Yusuf S; CURE Economic Group. Lamy A, et al. Among authors: lindgren p. Eur J Cardiovasc Prev Rehabil. 2004 Dec;11(6):460-5. doi: 10.1097/01.hjr.0000152239.28456.36. Eur J Cardiovasc Prev Rehabil. 2004. PMID: 15580055 Clinical Trial.

8

The cost-effectiveness of early cabergoline treatment compared to levodopa in Sweden.

Lindgren P, Jönsson B, Duchane J. Lindgren P, et al. Eur J Health Econ. 2003;4(1):37-42. doi: 10.1007/s10198-002-0144-3. Eur J Health Econ. 2003. PMID: 15609167

9

Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

Lindgren P, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, Wedel H, Jönsson B; ASCOT investigators. Lindgren P, et al. Eur J Cardiovasc Prev Rehabil. 2005 Feb;12(1):29-36. Eur J Cardiovasc Prev Rehabil. 2005. PMID: 15703503 Clinical Trial.

10

The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.

Lindgren P, Stenestrand U, Malmberg K, Jönsson B. Lindgren P, et al. Clin Ther. 2005 Jan;27(1):100-10. doi: 10.1016/j.clinthera.2005.01.008. Clin Ther. 2005. PMID: 15763611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

545 results

Search Page

Filters